117 related articles for article (PubMed ID: 34686875)
21. Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
Cho WK; Kim YI; Park W; Yang K; Kim H; Cha H
Int J Gynecol Cancer; 2019 Sep; 29(7):1116-1120. PubMed ID: 31474588
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
24. [Analyses of risk factors for postoperative recurrence after curative resection of stage III A-N2 non-small cell lung cancer].
Qiang G; Guo Y; Xiao F; Yu Q; Liang C; Song Z; Tian Y; Shi B; Liu D
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(41):3239-43. PubMed ID: 25604225
[TBL] [Abstract][Full Text] [Related]
25. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
26. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract][Full Text] [Related]
27. Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.
Isaka T; Nakayama H; Ito H; Yokose T; Yamada K; Masuda M
BMC Cancer; 2018 Oct; 18(1):959. PubMed ID: 30290774
[TBL] [Abstract][Full Text] [Related]
28. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
29. Retroperitoneal lymph node recurrence of epithelial ovarian cancer: Prognostic factors and treatment outcome.
Levy T; Migdan Z; Aleohin N; Ben-Shem ; Peled O; Tal O; Elyashiv O
Gynecol Oncol; 2020 May; 157(2):392-397. PubMed ID: 32151375
[TBL] [Abstract][Full Text] [Related]
30. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.
Jiao XG; Deng JY; Zhang RP; Wu LL; Wang L; Liu HG; Hao XS; Liang H
World J Gastroenterol; 2014 Apr; 20(13):3640-8. PubMed ID: 24707149
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
33. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
34. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
35. Postoperative Complications and Cancer Recurrence: Impact on Poor Prognosis of Lower Lobe Cancer.
Ueda K; Murakami J; Tanaka T; Nakamura T; Yoshimine S; Hamano K
Ann Thorac Surg; 2020 Jun; 109(6):1750-1756. PubMed ID: 32057809
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy.
Moon Y; Sung SW; Park JK; Lee KY; Ahn S
World J Surg; 2019 Apr; 43(4):1162-1172. PubMed ID: 30536021
[TBL] [Abstract][Full Text] [Related]
37. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
38. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics.
Chiappetta M; Sperduti I; Ciavarella LP; Leuzzi G; Bria E; Mucilli F; Lococo F; Filosso P; Ratto G; Spaggiari L; Facciolo F; Margaritora S
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):315-323. PubMed ID: 32747930
[TBL] [Abstract][Full Text] [Related]
39. Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma.
Ito M; Miyata Y; Hirano S; Kimura S; Irisuna F; Ikeda K; Kushitani K; Kishi N; Tsutani Y; Takeshima Y; Okada M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2325-2333. PubMed ID: 31317326
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
